Overview

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Treatments:
Brinzolamide
Ophthalmic Solutions
Tetrahydrozoline
Timolol
Criteria
Inclusion Criteria:

- 18 years of age or older

- Diagnosis of open-angle glaucoma

- Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

- Under 18

- Pregnant

- Other protocol-defined exclusion criteria may apply